Introduction
Cell growth and dierentiation are highly coordinated processes, and a ®ne balance between these processes is critical for maintaining normal cellular function. Perturbation in growth control, as a result of aberrant expression of oncogenes or growth suppressor genes, can result in carcinogenesis. The products of growth suppressor genes function by negatively regulating cell growth and division (Greenblatt et al., 1994) . Consequently, loss of function through mutation or deletion of growth suppressor genes or down-regulation of growth suppressor gene products can result in unbalanced cell growth and dierentiation. Understanding the mechanism of action of a growth suppressor gene product may provide foundation for rational approach to cancer therapy.
C-CAMs are CEA-like adhesion molecules and members of the immunoglobulin (Ig) supergene family (Lin et al., 1991) . C-CAMs are primarily expressed in epithelial tissues and play important roles in the regulation of growth and dierentiation of these tissues. C-CAM expression was found to increase at the onset of hepatocyte dierentiation (Cheung et al., 1993c , Thompson et al., 1993 . Furthermore, there is a consistent decrease in C-CAM expression, at both the RNA and protein levels, in hepatocellular carcinoma (Hixson et al., 1985; Thompson et al., 1994) . Consistent with this, we also found that expression of C-CAM is decreased early in prostate carcinogenesis (Kleinerman et al., 1995a) . Rosenberg et al. (1993) and Neumaier et al. (1993) have also reported that mouse and human biliary glycoproteins (BGP), which are C-CAM homologues, were down regulated in colon tumor. These observations are consistent with the notion that expression of C-CAMs and C-CAM homologues may keep cells in the dierentiated states, while down regulation of the expression of these proteins may be an essential event in the development of epithelial malignancy. In other words, C-CAMs may function as growth suppressors in the epithelial tissues. We recently provided direct evidence that C-CAM1, an isoform of C-CAMs, could indeed function as a growth suppressor in prostate cancer. Transfection of C-CAM1 into prostate cancer cells reduced their tumorigenicity, suggesting that C-CAM1 is a growth suppressor of prostate cancer cells (Hsieh et al., 1995 , Kleinerman et al., 1995b .
While some tumor suppressor genes such as p53 are altered in a broad spectrum of cancer types (Greenblatt et al., 1994) , changes in function of other tumor suppressor genes are correlated only with speci®c tumor types. For example, while the adenomatous polyposis coli gene is expressed in all adult tissues, deletion or mutation of this gene has mainly been correlated with tumorigenicity of gastrointestinal tract, suggesting that there may be tissue-speci®c event for some tumor suppressor genes (Nagase and Nakamura, 1993) . Thus, studies on the tissue speci®city of a tumor suppressor gene are also necessary for understanding how inactivation of these genes contribute to human cancer.
So far, the growth suppressor role of C-CAM has been documented only in prostate cancer cells, it is not clear whether C-CAM also plays a similar role in other cancer cells. Since overexpression of oncogenes and inactivation of tumor suppressor genes have been implicated in breast-cancer progression, it is possible that C-CAM may also function as a growth suppressor in breast cancer. Breast cancer is a major cause of mortality in women in the United States, and the complexity of this malignancy presents a major challenge for cancer therapy. If C-CAM plays a role in breast cancer progression, this molecule may oer a new tool for the treatment of this cancer.
Cell adhesion molecules that function in recognition and binding between cells are of fundamental importance for proper functions of multicellular organisms. The observation that C-CAM has both adhesion and growth suppression activities suggests a possibility that the adhesion induced by this molecule may be the ®rst step and an integral part of the signal transduction leading to growth suppression. However, there is no evidence that the adhesion and growth suppression functions are indeed related events. Delineating the structural basis for C-CAM1-mediated cell adhesion and growth suppression functions may provide insights into how the adhesion function of C-CAM1 relates with its growth suppression function.
In this study, we demonstrated that C-CAM1, a C-CAM family isoform, could function as a suppressor of breast-cancer cells in vivo. In addition, we studied the structural basis of C-CAM1-mediated growth suppression by using C-CAM1 mutants with deletions in the cytoplasmic or extracellular domains.
Results
Eciency of C-CAM1 expression in MDA-MB-468 cells C-CAM was shown to be expressed in the epithelial cells of normal rat breast (Odin et al., 1988) . In both lactating and non-lactating mammary glands, positive staining for C-CAM was detected on the apical surfaces of all ductal cells (Odin et al., 1988) . Similarly, in human breast tissues C-CAM was localized to the luminal epithelial cells of normal ductal cells (Sahin A, Han E, Luo W and Lin SH, manuscript in preparation and Prall et al., 1996) . To study the eects of C-CAM1 expression on the in vivo tumorigenicity of the breast cancer cell line MDA-MB-468, we inserted a full-length C-CAM1 cDNA into an adenoviral vector and generated a C-CAM1 recombinant adenovirus (AdCAM1) as a gene transfer vehicle. The breast-tumor cell line MDA-MB-468 was highly tumorigenic when injected into nude mice (Table 1) . RNase protection using a probe generated from the cytoplasmic domain of human C-CAM1 homologue, BGP1 (Hinoda et al., 1988) , showed that there was no detectable BGP1 message suggesting the absence of human C-CAM1 in this cell line (data not shown). To determine the expression eciency of C-CAM1 in MDA-MB-468 cells, we infected them with AdCAM1 at various virus to cell (V/C) ratios. Because C-CAM1 is an integral transmembrane protein, the eciency of C-CAM1 expression was determined by¯uorescence-activated cell sorting (FACS) with a polyclonal antibody against C-CAM (Ab669) (Kleinerman et al., 1995b) . About 45, 56, 69, 73 and 86% of cells expressed C-CAM1 on their surfaces when infected with AdCAM1 at the V/C ratios of 5:1, 10:1, 20:1, 30:1, and 50:1, respectively, for 24 h (data not shown). In addition, the total amounts of protein expressed, as re¯ected by the increase in¯uorescence intensity, also increased as the V/C ratio increased (data not shown). These results suggest that MDA-MB-468 cells are susceptible to adenoviral infection and can eciently express and process the protein product of the C-CAM1 recombinant adenovirus.
We then studied the time course of C-CAM1 expression by infecting MDA-MB-468 cells at a V/C ratio of 10:1. One day post-infection, the viral particles were removed from the cells and the cells continued to grow in fresh medium for various times. The percentage of cells expression C-CAM1 increased with time ( Figure 1 ). Expression plateaued between 2 to 4 days after infection, when 98% of the cells demonstrated C-CAM1 expression on FACS analysis ( Figure  1 ). Decrease of C-CAM1 expression was detected at day 5 post-infection, consistent with the fact that expression of protein from recombinant adenoviral infection is transient in nature. These data suggest that a high percentage of cells were susceptible to infection by AdCAM1.
Eects of C-CAM1 on tumorigenicity of MDA-MB-468 cells
Although the eciency of C-CAM1 expression in MDA-MB-468 cells increased with increasing V/C ratios, infection with high V/C ratios also resulted in cytotoxicity, which could interfere with the interpretation of the eects of C-CAM1 on tumor growth. Therefore, we sought an optimal V/C ratio that would give maximum C-CAM1 expression without cytotoxicity. We infected cells with an antisense C-CAM1 recombinant adenovirus (AdCAM1-AS) at various V/ C ratios and examined the eects on tumorigenicity of the infected cells in vivo. No signi®cant viral toxicity was observed when the MDA-MB-468 cells were infected at a V/C ratio of 10:1 or lower (data not shown). Thus, further experiments were performed at a V/C ratio of 10:1.
To determine whether C-CAM1 expression could aect the tumorigenicity of human breast cancer cells in vivo, we infected MDA-MB-468 cells with AdCAM1 or AdCAM1-AS at a V/C ratio of 10:1. The eciency of infection, as determined by FACS analysis with Ab669, was 46% at 24 h after infection (Figure 2 ). Although the eciency of infection was only 46% at the time of injection, an increase in C-CAM1 expression over time in vivo is expected from the time course of C-CAM1 expression in vitro (Figure 1 ). The viability of cells were determined during FACS analysis and there were no signi®cant amounts of dead cells detected at the time of injection. The infected cells were injected subcutaneously into nude mice at 10 6 cells per site and tumor growth was monitored weekly. AdCAM1 infection reduced both the incidence and size of the tumors generated from MDA-MB-468 cells injected subcutaneously (Table 1, Figure 3 ). 
Domains of C-CAM1 required for growth suppression
The structural basis for C-CAM1-mediated growth suppression was determined by expressing mutant C-CAM1 proteins with various domains deleted and investigating their growth-suppressive activity in MDA-MB-468 cells. In previous studies, we have shown that expression of C-CAM1 in insect cells conferred an adhesive phenotype and that the ®rst immunoglobulin (Ig) domain was essential for adhesion (Cheung et al., 1993b) . To test whether adhesion is required for growth suppression, a recombinant C-CAM1 adenovirus lacking the ®rst Ig domain (AdCAM1-DD1; Figure 4a ) was used to infect MDA- Structural analysis of C-CAM1-mediated tumor suppression W Luo et al MB-468 cells. Additional C-CAM1 mutant adenoviruses with various deletions in the cytoplasmic domain were used to test whether the cytoplasmic domain is critical for growth suppression. In previous studies, we observed that a recombinant baculovirus bearing C-CAM1 deletion mutant containing a 10-amino-acid cytoplasmic domain (CAM1-H458) was able to promote adhesion between insect cells in vitro , but a recombinant baculovirus with C-CAM1 mutant containing a 6-amino-acid cytoplasmic domain (CAM1-G454 or C-CAM3) could not (Cheung et al., 1993a) . It is possible that the dierence in the adhesion activities of these two C-CAM1 mutants resulted from dierential processing of these two proteins in insect cells. Therefore, we further examined the adhesive and growth-suppressive activities of these two mutants in MDA-MB-468 cells. CAM1-H458 was used to examine whether adhesion activity is sucient to confer growth suppressive activity in the absence of cytoplasmic domain. Although the cDNA of C-CAM1 predicts a 53 kDa protein (Lin et al., 1991, Lin and Guidotti, 1989) , the mature C-CAM1 is a glycoprotein with a relative molecular mass of 110 kDa on SDS ± PAGE. C-CAM1 protein expressed from MDA-MB-468 cells after infection with AdCAM1 had a relative molecular peptide N-glycosidase F showed only one protein band of about 53 kDa (data not shown). Similarly, two related protein species were observed when the cells were infected with each C-CAM1 mutant recombinant virus ( Figure 4b ). The AdCAM1-DD1 mutant proteins were each about 20 kDa smaller than those of AdCAM1, because the deleted ®rst Ig domain contains 102 amino acids and three potential N-linked glycosylation sites (Lin and Guidotti, 1989) . In contrast, deletion in the cytoplasmic domain (Ad-CAM1-H458) decreased the masses of the proteins by only about *7 kDa as expected. The identities of the mutant proteins were further con®rmed by immunoprecipitation with antipeptide antibody against the cytoplasmic domain (anti-C3) (Lin et al., 1991) . As shown in Figure 4c , AdCAM1 and AdCAM1-DD1 proteins were immunoprecipitated with antibody anti-C3, but AdCAM1-H458 and AdCAM1-G454 proteins were not, consistent with the deletion of the cytoplasmic domains in the latter proteins.
To test the cell-adhesive activity of these various mutants, we performed cell-aggregation assays. MDA-MB-468 cells were infected with recombinant adenovirus at V/C ratio of 10:1. At 24 h after infection, the cells were trypsinized, and their ability to form aggregates was monitored. As shown in Table 2 , MDA-MB-468 cells expressing wild-type C-CAM1 protein were able to aggregate, as evidenced by the decrease in the percentage of single cells (about 50%), as compared with cells infected with control antisense adenovirus. Expression of AdCAM1-DD1 did not confer cell adhesion (Table 2) , which is consistent with our previous observations in the insect cell system (Cheung et al., 1993b) . Both AdCAM1-H458 and AdCAM1-G454 were able to cause MDA-MB-468 cells to aggregate. These results are in contrast to those of our insect cell studies, in which AdCAM1-G454 did not cause cell adhesion (Cheung et al., 1993a) . The discrepancy could be due to the dierent cell types used for expression and/or dierent amounts of protein expressed on these cells, as the extent of aggregation seemed to correlate with the extent of protein expression as determined by FACS analysis (Figure 2 and Table 2 ).
The growth-suppressive activities of the C-CAM1 mutants were studied by infecting MDA-MB-468 cells with the recombinant adenoviruses at a V/C ratio of 10:1. The eciency of infection was determined by¯ow cytometry at 24 h after infection. About 45% of the cells infected with AdCAM1, AdCAM1-DD1, or AdCAM1-H458, were positive for C-CAM staining (Figure 2 ), whereas about 80% of the cells infected with AdCAM1-G545 were positive for C-CAM staining (Figure 2 ). The reason for the higher eciency of AdCAM1-G545 expression is not clear. The infected cells were then injected subcutaneously into nude mice, and tumor growth was monitored weekly. AdCAM1-DD1 infection reduced both the tumor incidence and size in a fashion similar to that of infection with AdCAM1 (Table 1, Figure 3 ). These results suggest that the adhesion activity of C-CAM1 is not required for C-CAM1-mediated growth suppression. On the other hand, C-CAM1 mutants with deletions in their cytoplasmic domains (AdCAM1-H458 and AdCAM1-G454) did not suppress tumorigenicity and produced tumor incidences and volumes similar to those of the control (Table 1, Figure 3) . These results strongly suggest that the cytoplasmic domain of C-CAM1 is critical for C-CAM1-mediated growth suppression. The cytoplasmic domain of C-CAM1 contains several potential phosphorylation sites including a putative phosphorylation site for cAMP-dependent kinase and a tyrosine-kinase phosphorylation site. These candidate phosphorylation sites may be the regulatory elements for C-CAM1-mediated growth suppression. The putative tyrosine phosphorylation site (Tyr488) has a sequence homologous to that of the antigen-receptor homology domain , which is important for membrane-bound IgMmediated signal transduction in B-cells. In our previous studies, we have shown that C-CAM1 expressed in insect cells was phosphorylated at Tyr488 . This structural feature suggests that Tyr488 located in the cytoplasmic domain may be important for C-CAM1-mediated function. To test the role of the potential tyrosine kinase phosphorylation in C-CAM1-mediated growth suppression, C-CAM1 mutant adenovirus with mutation of Tyr488 to Phe488 (Ad-CAM1-F488) was used to infect MDA-MB-468 cells. Expression of CAM1-F488 in MDA-MB-468 cells was able to confer cell adhesion (Table 2) , similar to those of our insect cell studies .
The eect of CAM1-F488 on the tumorigenicity of MDA-MB-468 cells was tested by infecting these cells with AdCAM1-F488. When tested in nude mice, these infected cells produce less tumor incidences and smaller tumor sizes similar to those of AdCAM1-infected cells (Table 1, Figure 3) suggesting that phosphorylation at Tyr488 is not required for C-CAM1-mediated growth suppression.
Discussion
This paper reports the growth suppression eect of C-CAM1 on the breast cancer cell line MDA-MB-468. Several conclusions can be drawn from this study. First, we showed that C-CAM1 suppressed the tumorigenicity of the breast-cancer cell line MDA-MB-468. This result suggests that C-CAM1 also function as a growth suppressor in breast carcinogenesis. Since expression of C-CAM1 was shown to suppress tumorigenicity of prostate cancer cells (Hsieh et al., 1995; Kleinerman et al., 1995b) , these observations suggest that C-CAM1 may be a general growth suppressor in epithelial cells. In addition, we identi®ed the cytoplasmic domain of C-CAM1 but not its extracellular domain critical for growth suppression. Thus, there is a clear separation of the domains required for adhesion and growth suppression functions and these two functions are independent of each other (Figure 4a ). Furthermore, we have found that mutation of the potential tyrosine phosphorylation site located in the cytoplasmic domain did not obliterate C-CAM1's functions. These observations are important for understanding the mechanism by which an adhesion molecule aects cellular growth.
In this study we used adenovirus as a gene transfer vehicle. Replication-de®cient adenoviral vectors have been used as a gene delivery vehicle to eciently transfer exogenous genes directly into tumor cells in both in vivo and in vitro applications (Mulligan, 1993) . In this study, we have also demonstrated the utility of this system in the structure and function study of a growth suppressor molecule. This system oers several advantages: First, transfection of a growth suppressor gene into cells often suppresses their growth. Thus, it is often dicult to select or clone cells expressing the suppressor gene (Hsieh et al, 1995 , Huang et al., 1988 . The high eciency of gene transfer oered by adenovirus makes it unnecessary to select or clone these cells, since a high percentage of cells will express the gene of interest after infection. Second, adenoviral DNA does not integrate into the cellular genome. Without integration, this system has a lower risk of activating other cellular genes. As a result, one is less likely to have integration artifacts commonly associated with gene transfection. Third, adenovirus can infect a wide range of cell types. This property makes it possible to compare the functional roles of a growth suppressor in dierent cell types and various tumor lineages.
That the cytoplasmic domain is critical for C-CAM1-mediated growth suppression has signi®cant implications. It strongly suggests that the cytoplasmic domain of C-CAM1 is involved in a signal-transduction pathway leading to altered cell growth. Similar result was also obtained from studies using mouse C-CAM isoforms (Kunath et al., 1995) . Kunath et al. (1995) showed that mouse colon carcinoma cells expressing the mouse C-CAM protein with a shorter cytoplasmic domain formed tumors while those expressing the longer cytoplasmic domain inhibited tumor growth. C-CAM1 and its isoforms are highly homologous to carcinoembryonic antigen (CEA) subfamily (Lin et al., 1991) . C-CAMs are unique among the CEAfamily proteins in that C-CAMs have cytoplasmic domains. Although the potential kinase phosphorylation sequences in C-CAM1 may be the regulatory elements for C-CAM1-mediated signal transduction, Figure 5 Comparison of the amino acid sequences of the cytoplasmic domain of rat C-CAM1 with human and mouse biliary glycoprotein
Structural analysis of C-CAM1-mediated tumor suppression W Luo et al we have ruled out the involvement of Tyr488 in C-CAM1-mediated growth suppression. The involvement of other phosphorylation sequences needs to be further investigated. However, it is also possible that C-CAM1-mediated growth suppression may be phosphorylation-independent. Since C-CAM1 is a membrane protein, other proteins must participate in the signal transduction pathway to relay the message in order to eect the cell growth suppression. Therefore, de®ning the molecule(s) which interact with the C-CAM1 cytoplasmic domain will be essential for understanding the mechanism of C-CAM1-mediated growth suppression.
In this study, we also showed that a rat adhesion molecule C-CAM1, whose human homologue is BGP1, can function as a growth suppressor in human breast cancer cell line. The fact that this molecule can function in dierent species and in dierent tumor cell lines, i.e. prostate and breast cancer cell lines, suggests that the function and mechanism of C-CAM1 is highly conserved. This in turn suggests the fundamental importance of the functions mediated by C-CAM1. Furthermore, this important function is likely unique to C-CAM family proteins because a search of the gene data bank did not turn up any signi®cant homology with other molecules. Sequence comparison between rat, mouse, and human homologues of C-CAM1 indicates that the cytoplasmic domains of these molecules are highly homologous with more than 60% identity ( Figure 5 ). This high degree of homology will explain the cross-species reactivity of this molecule. The high degree of homology of these cytoplasmic domains will predict a conserved structure which may interact with common (or similar) molecule to relay the signals leading to the suppression of cell growth. Indeed, secondary structure prediction using Chou and Fasman (1978) or Garnier's (Garnier et al., 1978) method showed that these molecules all have similar secondary structure arrangement, which likely will dictate the formation of similar tertiary structures. The high degree of homology also predicts that the important regulatory elements in the cytoplasmic domain of C-CAM1 are likely conserved across species, consistent with results from this study.
Because expression of C-CAM1 in cells conferred cell adhesion, adhesion induced by this molecule may be the ®rst step and an integral part of the signal transduction. However, in this study we showed that the growth suppression conferred by C-CAM1 is not dependent on its adhesion activity. This observation suggests that the growth suppressive activity of C-CAM1 is not initiated by the extracellular adhesion event. As a result, it is possible that the cytoplasmic domain alone may be sucient to initiate the signal transduction and the subsequent growth suppression. If so, further elucidation of the structural features in the C-CAM1 cytoplasmic domain that are responsible for this important function may eventually provide a foundation for rational design of compounds that can be used in cancer therapy.
The observation that C-CAM1-mediated growth suppression is not dependent on adhesion also raises questions concerning the functional signi®cance of the adhesion activity of C-CAM1. In liver and intestine, CCAMs are expressed on the apical surfaces of the epithelial cells (Odin et al., 1988) , where intercellular adhesion does not occur. The apical localization of C-CAM1 together with the observation that adhesion is not required for growth suppression suggest that the adhesion activity of C-CAM1 may be involved in other yet unidenti®ed functions.
The mechanism by which C-CAM1 mediates the growth suppression is not known. The possibility that expression of C-CAM1 and its mutants may aect endogenous BGP expression was investigated by RNase protection. However, no evidence of human BGP expression was found in our transient transfection samples (data not shown). This result suggests that expression of C-CAM did not aect endogenous BGP expression. Thus, the tumor suppressive eects seen are due to C-CAM expression rather than activation of endogenous BGP gene. The fact that the cytoplasmic domain of C-CAM1 is required for this function suggests that C-CAM1 may suppress the tumorigenicity of breast-tumor cells by transmission of speci®c signals through its cytoplasmic domain.
Materials and methods

Construction of recombinant adenoviruses
Recombinant adenoviruses containing the full-length wildtype C-CAM1 cDNA in the sense (AdCAM1) and antisense (AdCAM1-AS) orientations have been described previously (Kleinerman et al., 1995b) . To construct the AdCAM1-DD1 virus, a 1.5 kb HindIII ± NotI fragment containing the C-CAM1 cDNA lacking the ®rst Ig domain was isolated from pCR1000-DD1 (Cheung et al., 1993b) and inserted into an adenovirus shuttle vector, pXCMV, to generate the plasmid pXCMV-CAM1-DD1. The recombinant adenovirus AdCAM1-DD1 was generated by cotransfection of the plasmids pXCMV-CAM1-DD1 and pJM17, a vector that contains the adenovirus genome, into the human embryonal kidney cell line 293 as described previously (Kleinerman et al., 1995b) .
To construct the AdCAM-H458 virus, the CAM-H458 cDNA fragment with¯anking HindIII ± NotI sites was generated by polymerase chain reaction ampli®cation with oligonucleotides 5'-GTCGACAAGCTTATGGAGCTAGC-CTCGGCTCGTCTC-3' and 5'-GCGGCCGCGTCGACGG-TATCGATAAGGTTGATATC-3' as primers (the HindIII and NotI sites are underlined) using pSK-H458 as the template. The 1.6 kb product was subcloned into pCRII to yield pCRII-Adeno-H458. The DNA fragment coding for CAM1-H458 was isolated from pCRII-Adeno-H458 by digestion with HindIII and NotI, and the fragment was inserted into the adenoviral shuttle vector pXCMV at the HindIII-NotI site to generate pXCMV-CAM1-H458. Ad-CAM1-H458 was generated by co-transfection as described above.
The AdCAM1-F488 virus, in which Tyr-488 was mutated to Phe-488, was generated similar to those of AdCAM1-H458 except that plasmid pSK-F488 was used as the template.
Detection of C-CAM protein by FACS analysis
MDA-MB-468 cells were infected with recombinant adenovirus at various virus to cell (V/C) ratios as indicated. After 24 h,¯uorescence staining of C-CAM expressing cells was performed with an anti-C-CAM polyclonal antibody (Ab669) and¯uorescein isothiocyanate-conjugated secondary antibodies as described previously (Cheung et al., 1993b) . FACS analysis was performed as described previously (Hsieh et al., 1995) .
Immunoprecipitation and Western blotting
To analyse the C-CAM1 proteins expressed in MDA-MB-468 cells, aliquots of cell lysate from infected and uninfected cells were boiled in sodium dodecyl sulfate (SDS) sample buer and analysed by SDS-polyacrylamide gel electrophoresis (Laemmli, 1970) . Western immunoblotting with Ab669 was performed as previously described . To immunoprecipitate the C-CAM1 proteins expressed in MDA-MB-468 cells, aliquots of cell lysate (50 ml) from infected MDA-MB-468 cells were mixed with an equal volume of denaturing buer (1 mM EDTA, 1% SDS, and 1 mM dithiothreitol, pH 8.0) and boiled for 5 min. After removal of insoluble material by centrifugation, the supernatants were diluted with immunoprecipitation buer (150 mM NaCl, 1 mM EDTA, 0.5% deoxycholate, 1% Nonidet P-40, and 25 mM Tris-HCl, pH 7.5) to a ®nal volume of 1 ml and incubated with 3 ml of antipeptide antibody (anti-C3) (Lin et al., 1991) and 20 ml of protein G-Sepharose (Pharmacia Inc., Piscataway, NJ) for 16 h at 48C with constant mixing. The immunoprecipitates were washed once with 0.8 ml of immunoprecipitation buer containing 0.1 ml of saturated NaCl, then with 0.8 ml of immunoprecipitation buer containing 0.1% SDS, and ®nally with 0.8 ml of immunoprecipitation buer alone. The materials bound to protein G-Sepharose were eluted by boiling the protein G-Sepharose in SDS sample buer.
Cell adhesion assay
MDA-MB-468 cells were infected with AdCAM1 or its mutants. Twenty-four h after infection, the cells were trypsinized from the tissue-culture plates and resuspended in phosphate-buered salines. These cell suspensions (1 ml) were mixed gently at room temperature to allow the formation of cell aggregates. The number of single cells remaining in suspension was determined with a hemacytometer after 5 h. The extent of cell aggregation was expressed as the decrease in the percentages of single cells.
Tumorigenicity in nude mice
MDA-MB-468 cells were infected with recombinant adenovirus at various V/C ratios as indicated. Twentyfour h after infection, the cells were removed from the plates by trypsin digestion and washed twice with phosphate-buered saline. One million cells were then injected subcutaneously into each of six sites in the left and right¯anks of nude mouse and tumor growth was monitored weekly. Tumor volume was estimated by the method of Rockwell et al. (1972) .
